Last reviewed · How we verify
NCT05243134
The Influence of Anatomic Deformities on the Clinical Efficacy in the Patients With Patellar Dislocation
trial testing Collect the clinical data in Patellar Dislocation in 1,000 participants. Status unknown.
30 December 2025
Quick facts
| Lead sponsor | Peking University Third Hospital |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 1,000 |
| Start date | 30 September 2021 |
| Primary completion | 30 December 2025 |
| Estimated completion | 30 December 2025 |
| Sites | 1 location across China |
Drugs / interventions tested
- Collect the clinical data
Conditions studied
- Patellar Dislocation — all drugs for Patellar Dislocation →
- Anatomic Abnormality — all drugs for Anatomic Abnormality →
- Trochlear Dysplasia — all drugs for Trochlear Dysplasia →
- Femoral Anteversion — all drugs for Femoral Anteversion →
Sponsor
Peking University Third Hospital
Who can join
Adults 14 to 40, any sex, with Patellar Dislocation or Anatomic Abnormality. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
All the data of patients with patellar dislocation will be collected to evaluate the anatomic deformities. The data includes X-ray, CT, MRI examinations, medical records, and physical examination information. Finally, we correlate the anatomic deformities with clinical efficacy. To search for the risk factors that lead to patellar dislocation and influence the therapeutic effect.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05243134
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Patellar Dislocation
Currently open trials in the same condition.
- NCT06086080 — Non-operative Treatment in First-time Patellar Dislocation · NA · recruiting
- NCT04607538 — The Faroese Knee Cohort: Etiology and Long-term Implications of Trochlear Dysplasia and Patellar Dislocations. · recruiting
- NCT04554212 — Blood Flow Restriction Training After Patellar INStability · NA · recruiting
- NCT04294199 — Effect of Early Range of Motion Following First Time Patellar Dislocation · NA · active not recruiting
- NCT05706363 — Comparison of Two Graft Choices in Mediale Patellofemoral Ligament Reconstruction (MPFL) · NA · active not recruiting
Other Peking University Third Hospital trials
Trials by the same sponsor.
- NCT07532421 — Probiotic Intervention on the Development of Allergic Diseases in Infants Exposed to Antibiotics Early in Life · NA · not yet recruiting
- NCT07470255 — Detection of Diabetic Foot Skin Damage Using Plantar Mechanical Parameters · not yet recruiting
- NCT07453381 — Multisensor Wireless Pressure Microcatheter For Microvascular Function Assessment In ANOCA/INOCA Patients: A Prospective · not yet recruiting
- NCT07452354 — AI-Based Diabetic Foot Recurrence Cohort · not yet recruiting
- NCT07423819 — Sports Rehabilitation Therapy for Knee Joint Sports Injuries: A Case Study of Anterior Cruciate Ligament Injury and Pate · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05243134 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Peking University Third Hospital
- Last refreshed: 16 February 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05243134.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing